+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-Retroviral Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • PDF Icon

    Report

  • 95 Pages
  • January 2024
  • Region: Global
  • Prof Research
  • ID: 5926505
Description Jump to:

Quick Summary:

In an industry where innovation and precision are paramount, our comprehensive report on the Anti-Retroviral Drugs market is an indispensable resource for senior business executives. The landscape of therapeutics for viral infections is evolving rapidly, making informed decision-making critical to maintaining a competitive edge. This meticulously assembled market analysis offers a lens into the industry's progress, exploring the development of drug segments such as NRTIs, NNRTIs, and integrase inhibitors, among others.

Our extensive research covers a breadth of data from regional market dynamics to in-depth competitor intelligence. Harnessing the scope of this report will equip your business to navigate the competitive anti-retroviral drugs market with confidence. Detailed profiles of influential players like Gilead Sciences, Pfizer, and others are paired with SWOT analyses, providing a strategic understanding of both opportunities and challenges. With actionable insights spanning over a decade, this report anchors your strategic planning in robust analysis and industry foresight.

This report describes the global market size of Anti-Retroviral Drugs from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment, regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes key players of Anti-Retroviral Drugs as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Types Segment:

  • Nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs)
  • Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
  • Protease inhibitors
  • Fusion inhibitors
  • CCR5 antagonists
  • Post-attachment inhibitors
  • Integrase strand transfer inhibitors (INSTIs)

Companies Covered:

  • Gilead Sciences
  • GSK
  • Pfizer
  • Roche
  • Abbott and Boehringer Ingelheim
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Anti-Retroviral Drugs Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Anti-Retroviral Drugs Market in North America (2019-2029)
8.1 Anti-Retroviral Drugs Market Size
8.2 Anti-Retroviral Drugs Market by End Use
8.3 Competition by Players/Suppliers
8.4 Anti-Retroviral Drugs Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Anti-Retroviral Drugs Market in South America (2019-2029)
9.1 Anti-Retroviral Drugs Market Size
9.2 Anti-Retroviral Drugs Market by End Use
9.3 Competition by Players/Suppliers
9.4 Anti-Retroviral Drugs Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Anti-Retroviral Drugs Market in Asia & Pacific (2019-2029)
10.1 Anti-Retroviral Drugs Market Size
10.2 Anti-Retroviral Drugs Market by End Use
10.3 Competition by Players/Suppliers
10.4 Anti-Retroviral Drugs Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Anti-Retroviral Drugs Market in Europe (2019-2029)
11.1 Anti-Retroviral Drugs Market Size
11.2 Anti-Retroviral Drugs Market by End Use
11.3 Competition by Players/Suppliers
11.4 Anti-Retroviral Drugs Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Anti-Retroviral Drugs Market in MEA (2019-2029)
12.1 Anti-Retroviral Drugs Market Size
12.2 Anti-Retroviral Drugs Market by End Use
12.3 Competition by Players/Suppliers
12.4 Anti-Retroviral Drugs Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Anti-Retroviral Drugs Market (2019-2024)
13.1 Anti-Retroviral Drugs Market Size
13.2 Anti-Retroviral Drugs Market by End Use
13.3 Competition by Players/Suppliers
13.4 Anti-Retroviral Drugs Market Size by Type
Chapter 14 Global Anti-Retroviral Drugs Market Forecast (2024-2029)
14.1 Anti-Retroviral Drugs Market Size Forecast
14.2 Anti-Retroviral Drugs Application Forecast
14.3 Competition by Players/Suppliers
14.4 Anti-Retroviral Drugs Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Gilead Sciences
15.1.1 Company Profile
15.1.2 Main Business and Anti-Retroviral Drugs Information
15.1.3 SWOT Analysis of Gilead Sciences
15.1.4 Gilead Sciences Anti-Retroviral Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.2 GSK
15.2.1 Company Profile
15.2.2 Main Business and Anti-Retroviral Drugs Information
15.2.3 SWOT Analysis of GSK
15.2.4 GSK Anti-Retroviral Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.3 Pfizer
15.3.1 Company Profile
15.3.2 Main Business and Anti-Retroviral Drugs Information
15.3.3 SWOT Analysis of Pfizer
15.3.4 Pfizer Anti-Retroviral Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.4 Roche
15.4.1 Company Profile
15.4.2 Main Business and Anti-Retroviral Drugs Information
15.4.3 SWOT Analysis of Roche
15.4.4 Roche Anti-Retroviral Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.5 Abbott and Boehringer Ingelheim
15.5.1 Company Profile
15.5.2 Main Business and Anti-Retroviral Drugs Information
15.5.3 SWOT Analysis of Abbott and Boehringer Ingelheim
15.5.4 Abbott and Boehringer Ingelheim Anti-Retroviral Drugs Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Anti-Retroviral Drugs Report
Table Data Sources of Anti-Retroviral Drugs Report
Table Major Assumptions of Anti-Retroviral Drugs Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Anti-Retroviral Drugs Picture
Table Anti-Retroviral Drugs Classification
Table Anti-Retroviral Drugs Applications
Table Drivers of Anti-Retroviral Drugs Market
Table Restraints of Anti-Retroviral Drugs Market
Table Opportunities of Anti-Retroviral Drugs Market
Table Threats of Anti-Retroviral Drugs Market
Table COVID-19 Impact For Anti-Retroviral Drugs Market
Table Raw Materials Suppliers
Table Different Production Methods of Anti-Retroviral Drugs
Table Cost Structure Analysis of Anti-Retroviral Drugs
Table Key End Users
Table Latest News of Anti-Retroviral Drugs Market
Table Merger and Acquisition
Table Planned/Future Project of Anti-Retroviral Drugs Market
Table Policy of Anti-Retroviral Drugs Market
Table 2019-2029 North America Anti-Retroviral Drugs Market Size
Figure 2019-2029 North America Anti-Retroviral Drugs Market Size and CAGR
Table 2019-2029 North America Anti-Retroviral Drugs Market Size by Application
Table 2019-2024 North America Anti-Retroviral Drugs Key Players Revenue
Table 2019-2024 North America Anti-Retroviral Drugs Key Players Market Share
Table 2019-2029 North America Anti-Retroviral Drugs Market Size by Type
Table 2019-2029 United States Anti-Retroviral Drugs Market Size
Table 2019-2029 Canada Anti-Retroviral Drugs Market Size
Table 2019-2029 Mexico Anti-Retroviral Drugs Market Size
Table 2019-2029 South America Anti-Retroviral Drugs Market Size
Figure 2019-2029 South America Anti-Retroviral Drugs Market Size and CAGR
Table 2019-2029 South America Anti-Retroviral Drugs Market Size by Application
Table 2019-2024 South America Anti-Retroviral Drugs Key Players Revenue
Table 2019-2024 South America Anti-Retroviral Drugs Key Players Market Share
Table 2019-2029 South America Anti-Retroviral Drugs Market Size by Type
Table 2019-2029 Brazil Anti-Retroviral Drugs Market Size
Table 2019-2029 Argentina Anti-Retroviral Drugs Market Size
Table 2019-2029 Chile Anti-Retroviral Drugs Market Size
Table 2019-2029 Peru Anti-Retroviral Drugs Market Size
Table 2019-2029 Asia & Pacific Anti-Retroviral Drugs Market Size
Figure 2019-2029 Asia & Pacific Anti-Retroviral Drugs Market Size and CAGR
Table 2019-2029 Asia & Pacific Anti-Retroviral Drugs Market Size by Application
Table 2019-2024 Asia & Pacific Anti-Retroviral Drugs Key Players Revenue
Table 2019-2024 Asia & Pacific Anti-Retroviral Drugs Key Players Market Share
Table 2019-2029 Asia & Pacific Anti-Retroviral Drugs Market Size by Type
Table 2019-2029 China Anti-Retroviral Drugs Market Size
Table 2019-2029 India Anti-Retroviral Drugs Market Size
Table 2019-2029 Japan Anti-Retroviral Drugs Market Size
Table 2019-2029 South Korea Anti-Retroviral Drugs Market Size
Table 2019-2029 Southeast Asia Anti-Retroviral Drugs Market Size
Table 2019-2029 Australia Anti-Retroviral Drugs Market Size
Table 2019-2029 Europe Anti-Retroviral Drugs Market Size
Figure 2019-2029 Europe Anti-Retroviral Drugs Market Size and CAGR
Table 2019-2029 Europe Anti-Retroviral Drugs Market Size by Application
Table 2019-2024 Europe Anti-Retroviral Drugs Key Players Revenue
Table 2019-2024 Europe Anti-Retroviral Drugs Key Players Market Share
Table 2019-2029 Europe Anti-Retroviral Drugs Market Size by Type
Table 2019-2029 Germany Anti-Retroviral Drugs Market Size
Table 2019-2029 France Anti-Retroviral Drugs Market Size
Table 2019-2029 United Kingdom Anti-Retroviral Drugs Market Size
Table 2019-2029 Italy Anti-Retroviral Drugs Market Size
Table 2019-2029 Spain Anti-Retroviral Drugs Market Size
Table 2019-2029 Belgium Anti-Retroviral Drugs Market Size
Table 2019-2029 Netherlands Anti-Retroviral Drugs Market Size
Table 2019-2029 Austria Anti-Retroviral Drugs Market Size
Table 2019-2029 Poland Anti-Retroviral Drugs Market Size
Table 2019-2029 Russia Anti-Retroviral Drugs Market Size
Table 2019-2029 MEA Anti-Retroviral Drugs Market Size
Figure 2019-2029 MEA Anti-Retroviral Drugs Market Size and CAGR
Table 2019-2029 MEA Anti-Retroviral Drugs Market Size by Application
Table 2019-2024 MEA Anti-Retroviral Drugs Key Players Revenue
Table 2019-2024 MEA Anti-Retroviral Drugs Key Players Market Share
Table 2019-2029 MEA Anti-Retroviral Drugs Market Size by Type
Table 2019-2029 Egypt Anti-Retroviral Drugs Market Size
Table 2019-2029 Israel Anti-Retroviral Drugs Market Size
Table 2019-2029 South Africa Anti-Retroviral Drugs Market Size
Table 2019-2029 Gulf Cooperation Council Countries Anti-Retroviral Drugs Market Size
Table 2019-2029 Turkey Anti-Retroviral Drugs Market Size
Table 2019-2024 Global Anti-Retroviral Drugs Market Size by Region
Table 2019-2024 Global Anti-Retroviral Drugs Market Size Share by Region
Table 2019-2024 Global Anti-Retroviral Drugs Market Size by Application
Table 2019-2024 Global Anti-Retroviral Drugs Market Share by Application
Table 2019-2024 Global Anti-Retroviral Drugs Key Vendors Revenue
Figure 2019-2024 Global Anti-Retroviral Drugs Market Size and Growth Rate
Table 2019-2024 Global Anti-Retroviral Drugs Key Vendors Market Share
Table 2019-2024 Global Anti-Retroviral Drugs Market Size by Type
Table 2019-2024 Global Anti-Retroviral Drugs Market Share by Type
Table 2024-2029 Global Anti-Retroviral Drugs Market Size by Region
Table 2024-2029 Global Anti-Retroviral Drugs Market Size Share by Region
Table 2024-2029 Global Anti-Retroviral Drugs Market Size by Application
Table 2024-2029 Global Anti-Retroviral Drugs Market Share by Application
Table 2024-2029 Global Anti-Retroviral Drugs Key Vendors Revenue
Figure 2024-2029 Global Anti-Retroviral Drugs Market Size and Growth Rate
Table 2024-2029 Global Anti-Retroviral Drugs Key Vendors Market Share
Table 2024-2029 Global Anti-Retroviral Drugs Market Size by Type
Table 2024-2029 Anti-Retroviral Drugs Global Market Share by Type

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Gilead Sciences
  • GSK
  • Pfizer
  • Roche
  • Abbott and Boehringer Ingelheim

Methodology

Loading
LOADING...

Related Topics

Related Reports

HIV integrase inhibitors - Pipeline Insight, 2024 - Product Image

HIV integrase inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • 60 Pages
  • Global
From
Human Immunodeficiency Virus Therapeutics Market Size, Share & Trends Analysis Report By Drug Type, By Drug Class (Entry & Fusion Inhibitors, Protease Inhibitors, Integrase Inhibitors), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Human Immunodeficiency Virus Therapeutics Market Size, Share & Trends Analysis Report By Drug Type, By Drug Class (Entry & Fusion Inhibitors, Protease Inhibitors, Integrase Inhibitors), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 75 Pages
  • Global
From
HIV Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

HIV Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 99 Pages
  • Global
From
HIV and AIDS Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Image

HIV and AIDS Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 87 Pages
  • Global
From
Global HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • 143 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.